Physician profile
Amelia Kate Hausauer
NPI 1376802082
$117,183.60
in general payments reported to CMS, 2019-2025
14 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $245 · 2021: $139 · 2022: $1,871 · 2023: $42K · 2024: $47K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $77K · Travel and Lodging: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $2,524 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $76,583.33 |
| Travel and Lodging | $19,340.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,200.00 |
| Food and Beverage | $2,524.29 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $104,803.62 | 2023-2025 | |
| Galderma Laboratories, L.P. | $6,383.56 | 2020-2025 | |
| Galderma Research & Development, LLC | $3,400.00 | 2023 | |
| Allergan, INC. | $1,841.26 | 2019-2022 | |
| Sientra, INC. | $309.06 | 2019-2021 | |
| Merz North America, INC. | $200.48 | 2022 | |
| Endo Pharmaceuticals INC. | $67.57 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $35.19 | 2022 | |
| Revance Therapeutics, INC. | $34.54 | 2025 | |
| Tepha INC | $29.41 | 2019 | |
| Motiva USA, LLC | $27.05 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $23.66 | 2025 | |
| Davol INC. | $14.81 | 2022 | |
| Medimetriks Pharmaceuticals, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amelia Hausauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.